Your shopping cart is currently empty

PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against the human lung adenocarcinoma epithelial cell line A549 in cellular assays.PARP-1-IN-2 induced apoptosis in A549 cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $41 | - | In Stock | |
| 5 mg | $103 | - | In Stock | |
| 10 mg | $167 | - | In Stock | |
| 25 mg | $279 | - | In Stock | |
| 50 mg | $397 | - | In Stock | |
| 100 mg | $538 | - | In Stock | |
| 200 mg | $691 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $110 | - | In Stock |
| Description | PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against the human lung adenocarcinoma epithelial cell line A549 in cellular assays.PARP-1-IN-2 induced apoptosis in A549 cells. |
| Targets&IC50 | PARP1:149 ± 11.0 nM |
| In vitro | PARP-1-IN-2 (compound 11g) (0-10 μM, 24-48 h) exhibits significant anti-proliferative activity against A549 cells without notable cytotoxicity on HFF cells.[1] PARP-1-IN-2 (0-10 μM, 24 h) reduces pro-caspase-3 and phosphorylated AKT expression, while increasing caspase-3, caspase-9 protein, and cleaved PARP-1 expression.[1] |
| Molecular Weight | 424.28 |
| Formula | C22H15Cl2N3O2 |
| Cas No. | 684234-55-7 |
| Smiles | Clc1ccc(cc1)-c1nn(CC(=O)Nc2cccc(Cl)c2)c(=O)c2ccccc12 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 9 mg/mL (21.21 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 0.5 mg/mL (1.18 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.